- Home
- HAE vs BHC Comparison
HAE vs BHC Comparison
Compare HAE & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAE
- BHC
- Stock Information
- Founded
- HAE 1971
- BHC N/A
- Country
- HAE United States
- BHC Canada
- Employees
- HAE N/A
- BHC N/A
- Industry
- HAE Medical/Dental Instruments
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- HAE Health Care
- BHC Health Care
- Exchange
- HAE Nasdaq
- BHC Nasdaq
- Market Cap
- HAE 2.3B
- BHC 2.4B
- IPO Year
- HAE 1991
- BHC N/A
- Fundamental
- Price
- HAE $48.89
- BHC $6.38
- Analyst Decision
- HAE Buy
- BHC Hold
- Analyst Count
- HAE 8
- BHC 2
- Target Price
- HAE $76.88
- BHC $9.00
- AVG Volume (30 Days)
- HAE 1.1M
- BHC 1.7M
- Earning Date
- HAE 11-06-2025
- BHC 10-29-2025
- Dividend Yield
- HAE N/A
- BHC N/A
- EPS Growth
- HAE 46.89
- BHC N/A
- EPS
- HAE 3.28
- BHC 0.27
- Revenue
- HAE $1,346,046,000.00
- BHC $9,858,000,000.00
- Revenue This Year
- HAE N/A
- BHC $6.28
- Revenue Next Year
- HAE $6.42
- BHC $3.76
- P/E Ratio
- HAE $15.11
- BHC $24.09
- Revenue Growth
- HAE 0.91
- BHC 7.13
- 52 Week Low
- HAE $47.32
- BHC $4.25
- 52 Week High
- HAE $94.99
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- HAE 37.27
- BHC 38.57
- Support Level
- HAE $47.56
- BHC $6.40
- Resistance Level
- HAE $50.60
- BHC $6.81
- Average True Range (ATR)
- HAE 1.38
- BHC 0.18
- MACD
- HAE 0.47
- BHC -0.02
- Stochastic Oscillator
- HAE 39.50
- BHC 5.00
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.